Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Differential Phenolic Compounds and Hormone Accumulation Patterns between Early- and Mid-Maturing Sweet Cherry (Prunus avium L.) Cultivars during Fruit Development and Ripening.
Ponce C, Kuhn N, Arellano M, Time A, Multari S, Martens S, Carrera E, Sagredo B, Donoso JM, Meisel LA. Ponce C, et al. Among authors: arellano m. J Agric Food Chem. 2021 Aug 11;69(31):8850-8860. doi: 10.1021/acs.jafc.1c01140. Epub 2021 Aug 2. J Agric Food Chem. 2021. PMID: 34339217 Free article.
ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study.
Maris M, Salles G, Kim WS, Kim TM, Lyons RM, Arellano M, Karmali R, Schiller G, Cull E, Abboud CN, Batlevi C, Kagiampakis I, Rebelatto MC, Lee Y, Kirby LC, Wang F, Bothos J, Townsley DM, Fathi AT, Ribrag V. Maris M, et al. Among authors: arellano m. Target Oncol. 2024 May;19(3):321-332. doi: 10.1007/s11523-024-01054-z. Epub 2024 Apr 29. Target Oncol. 2024. PMID: 38683495 Free PMC article. Clinical Trial.
Final phase I substudy results of ivosidenib in patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome.
DiNardo CD, Roboz GJ, Watts JM, Madanat YF, Prince GT, Baratam P, de Botton S, Stein AS, Foran JM, Arellano ML, Sallman DA, Hossain M, Marchione DM, Bai X, Patel PA, Kapsalis SM, Garcia-Manero G, Fathi AT. DiNardo CD, et al. Among authors: arellano ml. Blood Adv. 2024 Apr 19:bloodadvances.2023012302. doi: 10.1182/bloodadvances.2023012302. Online ahead of print. Blood Adv. 2024. PMID: 38640348
Acceptability of self-administered antigen test for COVID-19 in the Philippines.
Yang JEU, Jackarain FH, de Vergara TIM, Santillan JF, Reyes PWC, Arellano MCVB, Garcia JTU, Samonte SJG, Marfori AJG, Guerrero AMS. Yang JEU, et al. Among authors: arellano mcvb. Int J Technol Assess Health Care. 2024 Jan 17;40(1):e10. doi: 10.1017/S0266462324000035. Int J Technol Assess Health Care. 2024. PMID: 38230431
Translational research of new developments in targeted therapy of colorectal cancer.
Yang L, Atakhanova N, Arellano MTC, Mohamed MY, Hani T, Fahdil AA, Castillo-Acobo RY, Juyal A, Hussein AK, Amin AH, Pecho RDC, Akhavan-Sigari R. Yang L, et al. Among authors: arellano mtc. Pathol Res Pract. 2023 Dec;252:154888. doi: 10.1016/j.prp.2023.154888. Epub 2023 Oct 12. Pathol Res Pract. 2023. PMID: 37948996 Review.
296 results